Today Odyssey Healthcare, Inc. (NASDAQ: ODSY, $20.32) traded at prices 30% below yesterday’s high, despite announcing a 48% increase in net income. Investors in Medicare stocks (or readers of Barron’s Roundtable who were told about the wonderful profit opportunities in Medicare funded hospice companies) are clearly not happy with puny 48%growth.
Odyssey reported it made $31.2 million in net income on just a $6.4 million investment in property and equipment. That equals a 487.5% annual return. There are no publicly-traded organizations in the bank robbery game. So there’s no way of telling how profitable that activity is. But with the cost of get-away cars and burglary tools rising and the average size of a bank branch shrinking, one can only wonder about the number of enterprising bank robbers who are realizing that the easy money ain’t in banks no more but in Medicare.
All of Asensio & Company, Inc.’s reports are covered by the terms and conditions of the mandatory user agreement located at /?page_id=25. The statements below are a part of the user agreement whose entirety is incorporated herein by reference. These statements, and all of the statements contained in the mandatory user agreement, are intended to strictly limit our potential liability to you and your possible legal rights to the fullest extent of the law. Readers are advised to carefully read the entirety of the mandatory user agreement and strictly adhere to the directions given therein.
INVESTMENTS IN SECURITIES, COMMODITIES OR FUTURES HAVE INHERENT RISK, AND A PERSON TAKES SUCH RISKS KNOWINGLY AND BEARS FULL RESPONSIBILITY FOR HIS/HER OWN INVESTMENT RESEARCH AND DECISIONS. Use of this site is at your own risk. None of the information contained herein should be construed as an offer to sell or a solicitation of an offer to buy any securities. In cases where there exists controversy concerning a company’s disclosures, investors should not sell or buy their shares based on the theory that markets price securities efficiently. Furthermore, investors should not rely on the market to substitute for their own individual due diligence and deliberate decision making.
All of the information provided by Asensio & Company, Inc. at asensio.com must be taken as a whole and in its entirety. All of the statements on asensio.com involve, concern and are directed at public issues and public controversies of interest to the public at large. asensio.com contains no statements of fact. All of the statements published by asensio.com constitute written opinions and are not provided to assist any individual or entity in making any investment decision.